TIRAGOLUMAB

UNII:	6XG22YQM2Z
Formula:
Preferred Substance Name:	TIRAGOLUMAB

1918185-84-8
IMMUNOGLOBULIN G1-KAPPA, ANTI-( HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-456) (HOMO SAPIENS VH (IGHV6-1*01 (93%) (IGHD)-IGHJ4*01) (10.9.16) (1-126)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(223))) (127-456)) (229-220')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-220') (HOMO SAPIENS V-KAPPA (IGKV4-1*01 (97%) IGKJ3*01 (92%))(12.3.9) (1'-113')-HOMO SAPIENS IGKC*01 (114'-220'))DIMER (235-235'':238-238'')-BISDISULFIDE
MTIG7192A
MTIG-7192A
RG6058
RG-6058
RO7092284
RO-7092284
TIRAGOLUMAB [INN]
TIRAGOLUMAB [JAN]
TIRAGOLUMAB [USAN]
TIRAGOLUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TIRAGOLUMAB

Synonyms and Mappings

Resources